Business Context and Reporting Period
Company: 22nd Century Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 4, 2016
Reporting Period: Single event date (January 4, 2016)
The filing discloses a regulatory milestone regarding the Company's tobacco product portfolio. On January 4, 2016, the Company submitted a Modified Risk Tobacco Product application to the U.S. Food and Drug Administration (FDA).
Key Financial Metrics
This filing is a current report regarding a specific corporate event and does not contain financial statements, revenue figures, profit data, cash flow information, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.
Material Changes
There are no financial material changes reported in this document. The material change disclosed is the submission of a regulatory application to the FDA, which represents a strategic development in the Company's product lifecycle rather than a financial variance.
Guidance, Outlook, and Risks
- Management Commentary: The Company announced the submission of the Modified Risk Tobacco Product application via a press release (Exhibit 99.1).
- Outlook: The filing implies a potential pathway for regulatory approval of modified risk status, though no specific timeline or probability of approval is detailed in the text.
- Risks and Contingencies: The filing does not explicitly list risks or contingencies associated with the FDA application, though regulatory approval is inherently uncertain.
Investor Verification Checklist
- Verify the status and content of the Modified Risk Tobacco Product application submitted to the FDA.
- Review the full text of the press release (Exhibit 99.1) for specific product details and regulatory strategy.
- Monitor future FDA communications regarding the application's review status.
- Check subsequent filings for any financial impact or operational changes resulting from this regulatory submission.